Lv1
90 积分 2023-08-04 加入
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
10天前
已完结
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study
1个月前
已完结
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
1个月前
已完结
Prognostic impact of HER‐2/neu expression on squamous head and neck carcinomas
1个月前
已关闭
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
1个月前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
1个月前
已完结
Safety, Tolerability, and Preliminary Efficacy of Serplulimab, a Novel Anti-PD-1 Antibody, in Patients with Metastatic or Recurrent Solid Tumors: A Phase I Study
1个月前
已完结
Translational Insights and Overall Survival in the U31402-A-U102 Study of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC
4个月前
已完结
Efficacy of depatuxizumab mafodotin (ABT-414) in preclinical models of head and neck cancer
5个月前
已完结
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors
6个月前
已完结
皖公网安备34019202002308
